NOV
45
2
PDCO
77
3
R
55
-2
WAT
55
11
DUK
49
4
O
26
16
OMC
37
2
PSA
43
6
COP
36
2
RRC
52
2
EXPE
83
8
ROST
60
3
AIV
39
6
DG
14
6
USB
50
3
TXT
46
4
MCD
52
3
PPL
44
9
HST
53
4
PBI
30
-8
NOV
45
2
PDCO
77
3
R
55
-2
WAT
55
11
DUK
49
4
O
26
16
OMC
37
2
PSA
43
6
COP
36
2
RRC
52
2
EXPE
83
8
ROST
60
3
AIV
39
6
DG
14
6
USB
50
3
TXT
46
4
MCD
52
3
PPL
44
9
HST
53
4
PBI
30
-8
Financhill
Back

Relay Therapeutics Vs. Novo Nordisk AS Industry Stock Comparison

Sell
15

RLAY
Relay Therapeutics

Last Price:
$4.17
Seasonality Move:
-14.64%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Sell
15
Relay Therapeutics (RLAY) is a Sell

Is Relay Therapeutics a Buy, Sell or Hold?

  • The current Relay Therapeutics [RLAY] share price is $4.17. The Score for RLAY is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • RLAY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RLAY Stock Price Chart

What is Relay Therapeutics's stock price today?

  • The Relay Therapeutics share price today is $4.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLAY is experiencing selling pressure, which indicates risk of future bearish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

RLAY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.29 Sell
Relative Strength Index (14 RSI): 35.65 Sell
Chaikin Money Flow: -5188054 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.4 - 4.88) Sell
Bollinger Bands (100): (5.12 - 7.42) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

RLAY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.56 Sell
20-day SMA: 4.59 Sell
50-day SMA: 5.42 Sell
200-day SMA: 6.8 Sell
8-day EMA: 4.43 Sell
20-day EMA: 4.67 Sell
50-day EMA: 5.3 Sell
200-day EMA: 6.97 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

Relay Therapeutics Earnings Growth & RLAY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and a decrease next year of $0.08 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.

Relay Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):